Genertec Universal Medical Group Company Limited (abbrev. “UNI MEDICAL”) has filed its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited, covering the period ended 31 August 2026.
Issued Share Capital • The company’s issued ordinary shares were unchanged at 2.01 billion, with zero treasury shares on both 31 July and 31 August 2026. • No new shares were issued, repurchased, or cancelled during the month.
Public Float Compliance • UNI MEDICAL confirmed continued adherence to Main Board Rule 13.32D(1), maintaining a public float above the minimum 25% requirement.
Share Option Scheme Position • No share options were outstanding, granted, exercised, or cancelled in August. • The 2019 Share Option Scheme still allows for up to 155.57 million shares to be issued in future grants. • No funds were raised from option exercises during the month.
Other Equity Instruments • The company reported no outstanding warrants, convertibles, Hong Kong Depositary Receipts, or other share-linked agreements. • There were no other movements in issued or treasury shares.
Corporate Governance • The filing, submitted on 4 September 2026 by Executive Director Mr Chen Shisu, affirms full compliance with Hong Kong listing rules and all relevant legal and regulatory requirements.
Comments